Resources

Publications

09/21/2022
- Neuro/Psych
Prevalence of Pharmacogenomic Actionability in >11,000 Patients Receiving Psychiatric Care
PSYCH Congress 2022
09/20/2022
- Oncology
Racial Disparities in Tumor Profiling Testing Inferred From Continental Genetic Ancestry Determination of 100,000 Cancer Patients
AACR Cancer Health Disparities 2022
09/17/2022

Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta-Analysis of Prospective, Controlled Clinical Trials
American Society for Clinical Pharmacology and Therapeutics (ASCPT)
09/17/2022
- Oncology
Purity Independent Subtyping of Tumor (PurIST): Real-World Data Validation of a Pancreatic Ductal Adenocarcinoma (PDAC) Gene Expression Classifier and Its Prognostic Implications
AACR Pancreatic Cancer Special Session 2022
09/16/2022
- Neuro/Psych
Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta-Analysis of Prospective, Controlled Clinical Trials
Clinical Pharmacology & Therapeutics
09/09/2022
- Oncology
Safety, Tolerability and Efficacy of Agonist Anti-CD27 Antibody (Varlilumab) Administered in Combination With Anti PD-1 (Nivolumab) in Advanced Solid Tumors
Journal for ImmunoTherapy of Cancer
09/06/2022
- Oncology
Molecular Classification of Cancers of Unknown Primary Expands and Refines Treatment Options
ESMO 2022
09/06/2022
- Oncology
BRAF Mutations and Fusions in a Real-World Cohort of NSCLC Patients
ESMO 2022
09/06/2022
- Oncology
The Genomic Landscape of Small Cell Lung Cancer in Never Smoking Patients
ESMO 2022
08/03/2022
- Oncology
Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti–PD-L1 Immune Checkpoint Therapy
Journal of the National Cancer Institute

44 45 46